Shilpa Medicare Limited (NSE:SHILPAMED)
India · Delayed Price · Currency is INR 1,032.00
-5.70 (-0.55%)
Sep 24, 2026, 10:20 AM IST
Shilpa Medicare Market Cap
Shilpa Medicare has a market cap or net worth of 202.84 billion as of September 23, 2026. Its market cap has increased by 151.25% in one year.
Market Cap
202.84B
Enterprise Value
208.98B
Revenue
16.83B
Ranking
n/a
PE Ratio
68.22
Stock Price
1,032.00
ChartMarket Cap Chart
Since July 19, 1999, Shilpa Medicare's market cap has increased from 45.10M to 202.84B, an increase of 449,677.27%. That is a compound annual growth rate of 36.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 202.84B | 222.88% |
| Dec 31, 2025 | 62.82B | -11.35% |
| Dec 31, 2024 | 70.86B | 147.08% |
| Dec 29, 2023 | 28.68B | 18.74% |
| Dec 30, 2022 | 24.15B | -48.10% |
| Dec 31, 2021 | 46.54B | 26.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 381.12B |
| Wockhardt | 355.42B |
| Piramal Pharma | 285.34B |
| Eris Lifesciences | 179.49B |
| Cohance Lifesciences | 176.15B |
| Alivus Life Sciences | 171.88B |
| Alembic Pharmaceuticals | 166.83B |
| NATCO Pharma | 146.21B |